Checkpoint Therapeutics

$2.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-4.21%) Today
+$0.07 (+2.64%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CKPT and other stocks, options, and ETFs commission-free!

About CKPT

Checkpoint Therapeutics, Inc. Common Stock, also called Checkpoint Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers.

CEO
James F. Oliviero
Employees
10
Headquarters
New York, New York
Founded
2014
Market Cap
206.77M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
636.97K
High Today
$2.99
Low Today
$2.81
Open Price
$2.99
Volume
655.83K
52 Week High
$5.38
52 Week Low
$1.44

CKPT Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

WDC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure